Neurology:不宁腿综合征与女性高CVD死亡相关

2018-01-10 国际循环编辑部 国际循环

一项大规模护士健康研究数据的最新分析显示,伴不宁腿综合征(RLS)的女性心血管病(CVD)患者死亡风险较高。该研究在线发表于12月15日的Neurology。

一项大规模护士健康研究数据的最新分析显示,伴不宁腿综合征(RLS)的女性心血管病(CVD)患者死亡风险较高。该研究在线发表于12月15日的Neurology。

美国宾夕法尼亚州立大学的Xiang Gao及其同事纳入护士健康研究(Nurses'Health Study)中的57 417例妇女,平均年龄为67岁,且基线时(2002年)未患癌症、肾衰竭或心血管疾病。研究人员使用Cox比例风险模型,根据RLS状态、年龄、主要慢性病和其他潜在混杂因素,计算出全因和心血管死亡风险比(HR)。

结果显示,随访10年期间发生6448例死亡。医生诊断RLS与总死亡率增加风险之间无显著相关性(调整后HR=1.43,95%CI:0.98~1.34)。但是,在调整潜在混杂因素后,RLS女性心血管死亡率显著高于无RLS的妇女(调整后的HR=1.43,95%CI:1.02~2.00)。较长的RLS患病时间与较高的心血管死亡风险显著相关(P=0.04)。排除常见RLS合并症患者后,RLS与总死亡率(调整后HR=1.43,95%CI:1.03~1.97)和心血管死亡率(调整后HR=2.27,95%CI:1.21~4.28)的相关性增强。

Gao博士指出,该研究进一步证实RLS可能有重大临床意义,需认真对待。这不仅仅是一种良性的疾病。临床上,我们可以有一些方法来治疗RLS,例如,我们可以采用健康的生活方式可以减少症状。此外,大约一半的RLS患者缺铁,纠正缺铁可能有帮助。临床医生需注意RLS,测量这些患者的铁蛋白水平,低水平的患者应该服用铁补充剂。所有的患者都应接受生活方式的咨询。这也是首项发现有RLS的女性因特定原因而死亡的研究。既往曾发表过一组RLS男性全因死亡风险增加的研究,这次是针对女性人群。研究未显示RLS与癌症和其他原因引起的死亡率相关。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2000258, encodeId=e4632000258bc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jan 21 01:35:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278659, encodeId=eca42e86592b, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jan 15 09:19:07 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431072, encodeId=a0d914310e225, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jan 12 12:35:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277315, encodeId=60152e731581, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Jan 10 22:11:56 CST 2018, time=2018-01-10, status=1, ipAttribution=)]
    2018-01-21 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=2000258, encodeId=e4632000258bc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jan 21 01:35:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278659, encodeId=eca42e86592b, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jan 15 09:19:07 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431072, encodeId=a0d914310e225, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jan 12 12:35:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277315, encodeId=60152e731581, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Jan 10 22:11:56 CST 2018, time=2018-01-10, status=1, ipAttribution=)]
    2018-01-15 大爰

    学习了谢谢分享!!

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2000258, encodeId=e4632000258bc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jan 21 01:35:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278659, encodeId=eca42e86592b, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jan 15 09:19:07 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431072, encodeId=a0d914310e225, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jan 12 12:35:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277315, encodeId=60152e731581, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Jan 10 22:11:56 CST 2018, time=2018-01-10, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=2000258, encodeId=e4632000258bc, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Sun Jan 21 01:35:00 CST 2018, time=2018-01-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=278659, encodeId=eca42e86592b, content=学习了谢谢分享!!, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200816/e4675a86ea694f12b82202b320dc2654/12f6b900498349e994ce8f516a584d6a.jpg, createdBy=09431951290, createdName=大爰, createdTime=Mon Jan 15 09:19:07 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1431072, encodeId=a0d914310e225, content=<a href='/topic/show?id=f9b9e9124a8' target=_blank style='color:#2F92EE;'>#综合征#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79124, encryptionId=f9b9e9124a8, topicName=综合征)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Jan 12 12:35:00 CST 2018, time=2018-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=277315, encodeId=60152e731581, content=谢谢分享学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=57, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/Q3auHgzwzM7GibvIBibibnnnvpajk2stlDF5oichYahI6Bia8uxeTBFoPbdoHWebyXf9eal9FNgUF2lNcrwoZicM3BvQ/0, createdBy=a3742066385, createdName=戒馋,懒,贪, createdTime=Wed Jan 10 22:11:56 CST 2018, time=2018-01-10, status=1, ipAttribution=)]
    2018-01-10 戒馋,懒,贪

    谢谢分享学习了

    0

相关资讯

Sleep Med:普拉克索对中国中重度不宁腿综合征(RLS)有显著疗效

       不宁腿综合征(Restless legs Syndrome,RLS)是一种与睡眠密切相关的神经系统疾病,虽然发病机制目前尚未明了,但多项大型多中心临床试验都提示多巴胺受体激动剂能有效改善症状。然而,多巴胺受体激动剂在中国RLS患者的大规模临床试验尚未有报道。       上海交通大学医学院附属瑞金医院神经内

Circulation:不宁腿综合征与冠心病相关

根据一项最新的研究数据表明,为期至少3年的不宁腿综合征可增加冠状动脉心脏病的风险,这项研究(Nurses' Health Study)于9月11日在线发表于Circulation杂志。[Circulation. 2012 Sep 11] 主要研究者Yanping Li博士评论道:“一些横断面的研究已经发现不宁腿综合征和心脏疾病之间有关联,只是还没有在前瞻性研究中得到证实。现在,在一项新的前

普拉克索与心衰危险关系尚无定论

  2012年9月19日,美国食品与药物管理局(FDA)发表药物安全信息称,治疗帕金森病和不宁腿综合征药普拉克索可能增加患者心力衰竭(以下简称心衰)危险。但最近的研究结果显示,该药的潜在心衰危险还需进一步研究。   普拉克索是多巴胺受体激动剂。FDA分别于2008年和2010年收到了有关普拉克索的报告。报告显示,服用普拉克索的患者(n=12/4157)比服用安慰剂(n=4/2820)患者的新诊断